Patents for A61P 19 - Drugs for skeletal disorders (81,981)
09/2008
09/25/2008WO2008114054A1 Protease inhibitors
09/25/2008WO2008114022A1 Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents
09/25/2008WO2008113863A2 Nitrosated derivatives of 2,5-dihydroxybenzene compounds
09/25/2008WO2008051586A3 Anti-resorptive and bone building dietary supplements and methods of use
09/25/2008WO2008027585A3 Pyrrolo[3,2-d]pyrimidines that are selective antagonists of a2b adenosine receptors
09/25/2008US20080234467 Modifying amino acid sequences conjugate comprising: coupling N- alpha -protected amino acid to an immobilized peptide sequence, deprotecting sequence, cleaving peptide conjugate, recovering product
09/25/2008US20080234385 Method For Inhibiting Tnf-Alpha
09/25/2008US20080234370 Calcilytic Compounds
09/25/2008US20080234368 Therapeutic compositions and methods of use
09/25/2008US20080234362 Treatment for Asthma and Arthritis and Other Inflammatory Diseases
09/25/2008US20080234358 E-series of prostaglandin (EP) receptors; [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid
09/25/2008US20080234355 Dna methyl transferase inhibitors containing a zinc binding moiety
09/25/2008US20080234346 Pyrazalidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
09/25/2008US20080234307 Novel 6-Amino-Morphinan Derivatives, Method of Manufacturing Them and Their Application as Analgesics
09/25/2008US20080234285 Renin inhibitor such as (S),4(S),5(S),7(S) N-(3-amino-2,2-dimethyl-3-oxopropyl)-2,7-di(1-methylethyl)-4-hydroxy-5-amino-8-[4-methoxy-3-(3-methoxy-propoxy)phenyl]-octanamide and PDGF receptor tyrosine kinase inhibitor such as Imatinib, thrombosis, psoriasis, fibrosis, dermatosclerosis, atherosclerosis
09/25/2008US20080234283 Glutathione peroxidase mimetics for treatment of neurodegenerative, pulmonary and inflammatory diseases
09/25/2008US20080234268 Effective for prophylaxis and treatment of diseases, such as ("c-Met") hepatocyte growth factor receptor mediated diseases; N-(4-(3-amino-1H-indazol-4-yl)-3-fluorophenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide; treatment of neoplasia selected from lung, breast, colon cancer
09/25/2008US20080234260 Cysteine Protease inhibitors
09/25/2008US20080234242 angiogenesis inhibitor; antiinflammatory agents; immunosuppressants; steroids conjugated compound
09/25/2008US20080234219 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures
09/25/2008US20080234214 Seven or more contiguous ribose groups linked by achiral 5' to 3' internucleoside phosphate linkages; antisense agents for gene expression inhibition of a wide variety of pathological disorders such as autoimmune diseases; suitable for oral administration
09/25/2008US20080234199 Chemical Compounds
09/25/2008US20080234195 Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
09/25/2008US20080234189 Treatment of inflammation related to an autoimmune disease, such as asthma, arthritis, psoriasis, or inflammatory bowel disease by adminstering an extracellular adherence protein; recruitment of leukocytes or neutrophils to an inflammation site is prevented
09/25/2008US20080234179 Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form
09/25/2008US20080233217 Notoginseng radix extract inhibits release of tumor necrosis factor-alpha and is the death of activated T-cells only, so that it can be effectively used for the production of a medicine for preventing and treating arthritis and health food as well
09/25/2008US20080233216 Composition Comprising the Extract of Siegesbeckiae Herba For Preventing and Treating Arthritis and the Use Thereof
09/25/2008US20080233195 Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
09/25/2008US20080233185 Using dimethyl fumarate and/or diethyl fumarate, calcium alkyl fumarate, calcium methyl fumarate and/or calcium ethyl fumarate, zinc methyl fumarate and/or zinc ethyl fumarate, methyl hydrogen fumarate and/or ethyl hydrogen fumarate; sclerodermia, osteochondritis syphilitica (Wegener's disease)
09/25/2008US20080233165 Bone-growth stimulating particle of calcium sulfate compound, a resorbable polymer and a growth factor; a resorbable implant
09/25/2008US20080233127 Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitors
09/25/2008US20080233120 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology
09/25/2008US20080233113 Cardiovascular conditions, ischemia-reperfusion injury, atherosclerosis, inflammatory gastrointestinal disorder, pulmonary condition, musculoskeletal conditions, renal conditions, skin conditions, organ or tissue transplants, nervous system disorders
09/25/2008US20080233095 Method for obtaining antigen-specific tr1 regulatory lymphocytes
09/25/2008CA2682212A1 Anti-sclerostin antibodies
09/25/2008CA2681320A1 Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents
09/25/2008CA2680397A1 Novel adenine compound
09/25/2008CA2671303A1 Chymosin for the prevention and treatment of gastrointestinal disorders
09/24/2008EP1972638A1 Remedies for juvenile chronic arthritis and related diseases
09/24/2008EP1972615A1 Cycloalkanecarboxamide derivative and method for producing same
09/24/2008EP1972341A1 Pharmaceutical compositions comprising a bisphosphonate and vitamin D
09/24/2008EP1971369A2 Combination of anticholinergics, glucocorticoids, beta2-agonists, pde4 inhibitor and antileukotriene for the treatment of inflammatory diseases
09/24/2008EP1971226A2 High-potency sweetener composition for treatment and/or prevention of osteoporosis and compositions sweetened therewith
09/24/2008EP1865938A4 Dosing regimes for trans-clomiphene
09/24/2008EP1537096B1 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics
09/24/2008EP1509528B1 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/24/2008CN201120000Y Traditional Chinese medicine permeation plaster
09/24/2008CN101273057A Bone morphogenesis protein 2 active peptide and production method and application
09/24/2008CN101273039A Heterobicyclic compounds useful as p38 kinase inhibiting agents
09/24/2008CN101270140A Common camellia flavone glycosides B with estrogen liveness, preparation method and application thereof
09/24/2008CN101270139A Common camellia flavone glycosides A with estrogen liveness, preparation method and application thereof
09/24/2008CN101269213A Soluble preparation of bone morphogenesis protein-7 and application thereof
09/24/2008CN101269211A Shuangtang high calcium medicinal granule and preparation technique
09/24/2008CN101269178A Medicament for treating rheumatic disease and preparation method thereof
09/24/2008CN101269176A Quick-effective bones injury medicine
09/24/2008CN101269173A Chinese medicinal composition for treating osteomyelitis and preparation method thereof
09/24/2008CN101269167A Chinese medicine composing prescription for treating rheumatism, atrophic arthritis
09/24/2008CN101269157A Method for preparing wine for warming meridian, removing paralysism, releasing tendon, activating collaterals to relieve pain
09/24/2008CN101269108A Tripterygium wilfordii total terpene sustained-release dropping pill and preparation method thereof
09/24/2008CN101269094A Fruit and/or vegetable derived composition
09/24/2008CN101269073A Externally used anti-inflammatory pharmaceutical composition containing piketoprofen and preparation method thereof
09/24/2008CN101269034A Nimesulide sustained-release dropping pill and preparation method thereof
09/24/2008CN101269018A Leflunomide sustained-release dropping pills and preparation method thereof
09/24/2008CN101268901A Multifunctional cervical vertebra rehabilitation health care pillow with adjustable neck pillow height
09/24/2008CN100420690C Benzofuran compound, prepn. method and application thereof
09/24/2008CN100420476C Collateral-flow-activating external-use medicine of Herba et Radix Inebriantis for treating injuries by falls
09/24/2008CN100420475C Damp-repellent pain-relieving medicinal liquor of Rhizoma et Radix caulophy lei
09/24/2008CN100420473C Externally applied medicine of dunn tongoloa root
09/24/2008CN100420469C Damp-repellent pain-relieving medicine liquor of caulis seu Radix Parabarii Micranthi
09/24/2008CN100420466C Fracture-treating medicated liquor of Herba seu Radix peperomiae Tetraphyllate
09/24/2008CN100420462C Externally applied medicine of avicenna's pricklyash root
09/24/2008CN100420441C Use of flavone in preparing medicine for improving uric acid excretion
09/23/2008US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease
09/23/2008US7427638 Treatment may include administration of a second active agent, including but not limited to, an anti-inflammatory agent, an immnunosuppressant, mycophenolate mofetil, a biologic agent, or a Cox-2 inhibitor
09/23/2008US7427631 especially as inhibitors of MMP12
09/23/2008US7427628 N-(2-[N',N'-diethylamino]-5-[N''-(4-fluorophenylsulfonyl)-N''-propargylamino]pyrimidin-4-yl)-4'-(pyrrolidin-1-ylcarbonyloxy)-L-phenylalanine; antiinflammatory, antiarthritic agents
09/23/2008US7427626 useful in Pharmaceutical medicines or pharmacological tools; cytostatic agents; antiproliferative/antineoplastic agents; 2-Anilino-4-[1-isopropyl-2-(hydroxyiminomethyl)imidazol-5-yl]pyrimidine; rheumatoid arthritis; breast cancer
09/23/2008US7427623 4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof
09/23/2008US7427616 e.g. 8-(1-methyl-4-phenyl-1H-imidazol-5-yl)-9H-purin-6-amine9-methyl-8-(1-methyl-4-phenyl-1H-imidazol-5-yl)-9H-purin-6-amine; Tie2 receptor tyrosine kinase and angiogenesis inhibitor; diabetic retinopathy, psoriasis, cancer, rheumatoid arthritis, atheroma, Kaposi's sarcoma and haemangioma
09/23/2008US7427608 Protection against and treatment of hearing loss
09/23/2008US7427498 Composition, methods and reagents for the synthesis of a soluble form of human PHEX
09/23/2008CA2432872C Pyrazole compounds useful as protein kinase inhibitors
09/23/2008CA2418313C Piperidine derivatives and agent comprising the derivative as active ingredient
09/23/2008CA2379747C Novel succinate derivative compounds useful as cysteine protease inhibitors
09/23/2008CA2371393C Use of bismuth subgallate in inhibition of production of nitric oxide synthase
09/23/2008CA2351727C Crystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione
09/23/2008CA2283643C Certain cyclic thio substituted acylaminoacid amide derivatives
09/23/2008CA2266479C Vitamin d analogues
09/21/2008CA2637157A1 Mesenchymal stem cells and uses therefor
09/18/2008WO2008112674A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
09/18/2008WO2008112646A1 Aminopyridines useful as inhibitors of protein kinases
09/18/2008WO2008111010A1 Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors
09/18/2008WO2008111009A1 Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
09/18/2008WO2008087461A3 Use of kynurenic acid and derivatives thereof in the treatment of conditions of the gastrointestinal tract accompanied by hypermotility and inflammation or gout or multiple sclerosis
09/18/2008WO2008061512A3 Dietetic foodstuff with an improved anti-inflammatory and free radical binding action
09/18/2008US20080227957 Reducing Immunogenicities of Immunoglobulins by Framework-Patching
09/18/2008US20080227954 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders
09/18/2008US20080227869 Substituted nitrobenzene derivatives as pharmaceutical and other uses thereof
09/18/2008US20080227862 histone deacetylase (HDAC) inhibitor useful in selectively inducing terminal differentiation, cell growth arrest and/or apoptosis of neoplastic cells; have a high bioavailability and gives high blood levels of the active compounds over a long time
09/18/2008US20080227833 Selective inhibitors of MMP-9 and/or MMP12; antiinflammatory agents for multiple sclerosis and fibrosis; 3R-[2,2-Dimethyl-1 S-(5-phenyl-[1,2,4]oxadiazol-3-yl)-propylcarbamoyl]-2S-hydroxy-5-methyl-hexanohydroxamic acid; bone resorption, metastases, rheumatoid arthritis, Crohn's disease